These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 34140164)

  • 1. Disimmune encephalopathy with onconeuronal antibodies in SARS-CoV-2 infected patients.
    Saenz Lafourcade C; Pinel González A; Martin Ávila G
    Med Clin (Barc); 2021 Dec; 157(12):e357-e358. PubMed ID: 34140164
    [No Abstract]   [Full Text] [Related]  

  • 2. Disimmune encephalopathy with onconeuronal antibodies in SARS-CoV-2 infected patients.
    Saenz Lafourcade C; Pinel González A; Martin Ávila G
    Med Clin (Engl Ed); 2021 Dec; 157(12):e357-e358. PubMed ID: 34786483
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF.
    Andriuta D; Roger PA; Thibault W; Toublanc B; Sauzay C; Castelain S; Godefroy O; Brochot E
    J Neurol; 2020 Oct; 267(10):2810-2811. PubMed ID: 32529577
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 encephalopathy: Clinical and neurobiological features.
    Uginet M; Breville G; Assal F; Lövblad KO; Vargas MI; Pugin J; Serratrice J; Herrmann FR; Lalive PH; Allali G
    J Med Virol; 2021 Jul; 93(7):4374-4381. PubMed ID: 33782993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reader Response: Acute Necrotizing Encephalopathy With SARS-CoV-2 RNA Confirmed in Cerebrospinal Fluid.
    Frontera JA; Lewis A; Yaghi S; Bhimraj A
    Neurology; 2021 Aug; 97(5):252. PubMed ID: 34341078
    [No Abstract]   [Full Text] [Related]  

  • 6. Encephalopathy and COVID-19: a case report.
    Lazraq M; Benhamza S; Saadaoui S; Hayar S; Louardi M; Moujahid H; Bensaid A; Miloudi Y; Harrar NE
    Pan Afr Med J; 2021; 38():139. PubMed ID: 33912309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies.
    Smyth D; Kyaw KM; Legister A; MacFarlane G; Sankar UU; Patel M; Clough C; Kulendran A; Mulroy E
    J Neurol Sci; 2021 Nov; 430():119982. PubMed ID: 34543933
    [No Abstract]   [Full Text] [Related]  

  • 8. A fatal case of COVID-19-associated acute necrotizing encephalopathy.
    Ziemele D; Ķauķe G; Skrējāne K; Jaunozoliņa L; Karelis G
    Eur J Neurol; 2021 Nov; 28(11):3870-3872. PubMed ID: 34655265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts, Thailand, April-June 2020.
    Chirathaworn C; Sripramote M; Chalongviriyalert P; Jirajariyavej S; Kiatpanabhikul P; Saiyarin J; Soudon C; Thienfaidee O; Palakawong Na Ayuthaya T; Brukesawan C; Chaiwanichsiri D; Intharasongkroh D; Wanlapakorn N; Chansaenroj J; Puenpa J; Yorsaeng R; Thitithanyanont A; Kitphati R; Mungaomklang A; Nagavajara P; Poovorawan Y
    PLoS One; 2020; 15(10):e0236905. PubMed ID: 33119712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encephalopathy and encephalitis during acute SARS-CoV-2 infection. Spanish Society of Neurology COVID-19 Registry.
    Abenza Abildúa MJ; Atienza S; Carvalho Monteiro G; Erro Aguirre ME; Imaz Aguayo L; Freire Álvarez E; García-Azorín D; Gil-Olarte Montesinos I; Lara Lezama LB; Navarro Pérez MP; Pérez Sánchez JR; Romero Delgado F; Serrano Serrano B; Villarreal Vitorica E; Ezpeleta Echávarri D
    Neurologia (Engl Ed); 2021 Mar; 36(2):127-134. PubMed ID: 33549369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute necrotizing encephalopathy due to SARS-CoV-2 in a pregnant female.
    Breit H; Radaideh Y; John S
    Neurol Sci; 2021 Oct; 42(10):3991-3994. PubMed ID: 34324121
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2.
    Lake DF; Roeder AJ; Kaleta E; Jasbi P; Pfeffer K; Koelbela C; Periasamy S; Kuzmina N; Bukreyev A; Grys TE; Wu L; Mills JR; McAulay K; Gonzalez-Moa M; Seit-Nebi A; Svarovsky S
    J Clin Virol; 2021 Dec; 145():105024. PubMed ID: 34781240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.
    Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H
    Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
    Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
    Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [COVID-19-related acute encephalopathy: physiopathological hypothesis].
    Uginet M; Stancu P; Bridel C; Serratrice J; Lalive PH; Coen M
    Rev Med Suisse; 2021 Apr; 17(736):810-815. PubMed ID: 33908716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic and features of SARS-CoV-2 infection in Gabon.
    Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
    Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients' Management.
    Speletas M; Kyritsi MA; Vontas A; Theodoridou A; Chrysanthidis T; Hatzianastasiou S; Petinaki E; Hadjichristodoulou C
    Front Immunol; 2020; 11():609242. PubMed ID: 33424863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects.
    Huynh A; Arnold DM; Smith JW; Moore JC; Zhang A; Chagla Z; Harvey BJ; Stacey HD; Ang JC; Clare R; Ivetic N; Chetty VT; Bowdish DME; Miller MS; Kelton JG; Nazy I
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33923828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19
    Yuen RR; Steiner D; Pihl RMF; Chavez E; Olson A; Smith EL; Baird LA; Korkmaz F; Urick P; Sagar M; Berrigan JL; Gummuluru S; Corley RB; Quillen K; Belkina AC; Mostoslavsky G; Rifkin IR; Kataria Y; Cappione AJ; Gao W; Lin NH; Bhadelia N; Snyder-Cappione JE
    Front Immunol; 2021; 12():614676. PubMed ID: 33897682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.